AB
BEAM icon

Amalgamated Bank’s Beam Therapeutics BEAM Stock Holding History

Amalgamated Bank’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,004
Closed -$83K – 1754
2025
Q4 		$83K Sell
3,004
-149
-5% -$3.8K ﹤0.01% 1723
2025
Q3 		$77K Hold
3,153
– – ﹤0.01% 1738
2025
Q2 		$54K Hold
3,153
– – ﹤0.01% 1812
2025
Q1 		$62K Buy
3,153
+534
+20% +$14K ﹤0.01% 1756
2024
Q4 		$65K Hold
2,619
– – ﹤0.01% 1779
2024
Q3 		$64K Hold
2,619
– – ﹤0.01% 1783
2024
Q2 		$61K Buy
2,619
+146
+6% +$3.59K ﹤0.01% 1813
2024
Q1 		$82K Sell
2,473
-7,345
-75% -$229K ﹤0.01% 1761
2023
Q4 		$267K Sell
9,818
-18
-0.2% -$447 ﹤0.01% 1704
2023
Q3 		$237K Hold
9,836
– – ﹤0.01% 1725
2023
Q2 		$314K Buy
9,836
+888
+10% +$28.8K ﹤0.01% 1653
2023
Q1 		$274K Sell
8,948
-1,543
-15% -$60.9K ﹤0.01% 1683
2022
Q4 		$410K Buy
10,491
+208
+2% +$9.32K ﹤0.01% 1556
2022
Q3 		$490K Buy
10,283
+243
+2% +$13.9K ﹤0.01% 1441
2022
Q2 		$389K Buy
10,040
+1,661
+20% +$66K ﹤0.01% 1587
2022
Q1 		$480K Sell
8,379
-625
-7% -$41K ﹤0.01% 1558
2021
Q4 		$718K Buy
9,004
+142
+2% +$12.2K 0.01% 1397
2021
Q3 		$771K Sell
8,862
-10
-0.1% -$1K 0.01% 1379
2021
Q2 		$1.14M Buy
8,872
+3,192
+56% +$254K 0.01% 1224
2021
Q1 		$455K Sell
5,680
-524
-8% -$49.8K 0.02% 1037
2020
Q4 		$506K Buy
+6,204
New +$305K 0.02% 961

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Amalgamated Bank's BEAM Position: Q1 2026 in Review

Amalgamated Bank sold out of Beam Therapeutics (BEAM) in Q1 2026, closing a stake of 3,004 shares — an estimated $83K sold.

Amalgamated Bank first reported a position in BEAM in Q4 2020 and held it in 21 quarters. The position peaked at $1.14M in Q2 2021. 251 funds tracked by Wall St. Rank hold BEAM as of Q1 2026.

  • Amalgamated Bank reported no remaining Beam Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 3,004 Beam Therapeutics shares in Q1 2026, an estimated $83K.
  • Amalgamated Bank first reported a position in Beam Therapeutics in Q4 2020 and held it in 21 quarters.
  • Amalgamated Bank's Beam Therapeutics position peaked at $1.14M in Q2 2021.
  • 251 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.